Asthma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027

Dec 2019| FMR581A| Fact Market Research

Report Highlights

Asthma Treatment Market - Scope of the Study

The study on the asthma treatment market is an exclusive study, which has been recently added to the broad report repository of Fact.MR. The study brings to light crucial influencers that have been influencing the growth of the asthma treatment market. This comprehensive study offers analytical insights pertaining to the recent developments in the asthma treatment market, through the analysis of historical data for the period of 2017-2019, while the duration 2020-2027 is considered as the forecast period.

Recalibration of revenue of the asthma treatment market has been carried out in terms of value (US$ Mn). This research report offers exclusive insights into the influential trends that hold high potential to shape the asthma treatment market during the forecast period. Besides this, the report also includes numerous macroeconomic and microeconomic growth indicators that support the growth of the asthma treatment market during the forecast period. This detailed guide offers crucial information into the key dynamics, along with their influence on the asthma treatment market during the forecast period.

The detailed report, in turn, brings to the fore, insightful information about key challenges and threats that could limit the growth potential of players in the asthma treatment market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global asthma treatment market. With a view of aiding stakeholders in the asthma treatment market, the study comprises a detailed section on the competition analysis.

This exclusive study offers a dashboard view of the asthma treatment market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the asthma treatment market have also been included in this comprehensive study.

For more insights, request sample of this report.

Revenue of the asthma treatment market has been estimated in terms of US$ Mn for the period of 2020 to 2027. In addition to this, compound annual growth rate (CAGR %) has been estimated for all segments during the forecast period 2020-2027, considering 2019 as the base year, in the asthma treatment market.

Analysts of the research report have studied the profiles of key companies operating in the asthma treatment market to get a thorough idea of the competitive landscape. Leading, prominent, and emerging players profiled in this exclusive study include Mylan N.V., Teva Pharmaceutical Industries, AstraZeneca PLC., Sunovion Pharmaceutical, Inc., Boehringer Ingelheim, Sanofi, F.Hoffmann-La Roche Ltd., Novartis International AG, GlaxoSmithKline PLC, and Merck & Co., Inc.

Asthma Treatment Market - Research Methodology

The primary objective of this exclusive study on the asthma treatment market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2027. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the asthma treatment market, and recalibrate the adoption rate of asthma treatment in key regions across the world. Top-down and bottom-up approaches have also been adopted by research analysts in order to validate data and statistics to offer accurate market information to stakeholders.

  • Table 1 : Pipeline Analysis
  • Table 2 : Pipeline Analysis
  • Table 3 : Pipeline Analysis
  • Table 4 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 5 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 6 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 7 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 8 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 9 : Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region, 2020–2027
  • Table 10 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 11 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 12 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 13 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 14 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 15 : North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
  • Table 16 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 17 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 18 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 19 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 20 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 21 : Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
  • Table 22 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 23 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 24 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 25 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 26 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 27 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
  • Table 28 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 29 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 30 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 31 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 32 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 33 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
  • Table 34 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
  • Table 35 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2020–2027
  • Table 36 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2020–2027
  • Table 37 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
  • Table 38 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
  • Table 39 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
  • Figure 1 : Global Asthma Treatment Market Value (US$ Mn) and Distribution Channel, by Region, 2019 and 2027
  • Figure 2 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 3 : Global Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 4 : Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Long-term Asthma Control Medications, 2020–2027
  • Figure 5 : Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Quick-relief (rescue) Medications, 2020–2027
  • Figure 6 : Global Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027
  • Figure 7 : Global Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 8 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhaled, 2020–2027
  • Figure 9 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2020–2027
  • Figure 10 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2020–2027
  • Figure 11 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2020–2027
  • Figure 12 : Global Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 13 : Global Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 14 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2020–2027
  • Figure 15 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2020–2027
  • Figure 16 : Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2020–2027
  • Figure 17 : Global Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 18 : Global Asthma Treatment Market Value Share Analysis, by Region, 2019 and 2027
  • Figure 19 : Global Asthma Treatment Market Attractiveness Analysis, by Region, 2019–2027
  • Figure 20 : North America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 21 : North America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 22 : North America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027
  • Figure 23 : North America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 24 : North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 25 : North America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 26 : North America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 27 : North America Asthma Treatment Market Value Share Analysis, by Country, 2019 and 2027
  • Figure 28 : North America Asthma Treatment Market Attractiveness Analysis, by Country, 2019–2027
  • Figure 29 : Europe Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 30 : Europe Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 31 : Europe Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027
  • Figure 32 : Europe Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 33 : Europe Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 34 : Europe Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 35 : Europe Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 36 : Europe Asthma Treatment Market Value Share Analysis, by Country/Sub-Region, 2019 and 2027
  • Figure 37 : Europe Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 38 : Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 39 : Asia Pacific Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 40 : Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2027
  • Figure 41 : Asia Pacific Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 42 : Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 43 : Asia Pacific Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 44 : Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 - 2027
  • Figure 45 : Asia Pacific Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 46 : Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 47 : Latin America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 48 : Latin America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 49 : Latin America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027
  • Figure 50 : Latin America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 51 : North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 52 : Latin America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 53 : Latin America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 54 : Latin America Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 55 : Latin America Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 56 : Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020–2027
  • Figure 57 : Middle East & Africa Asthma Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2027
  • Figure 58 : Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027
  • Figure 59 : Middle East & Africa Asthma Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2027
  • Figure 60 : Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 61 : Middle East & Africa Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2027
  • Figure 62 : Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019?2027
  • Figure 63 : Middle East & Africa Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 64 : Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 65 : Global Asthma Treatment Market Share, by Company, 2019
  • Figure 66 : AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2019
  • Figure 67 : AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2019
  • Figure 68 : AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2019
  • Figure 69 : Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 70 : Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2019
  • Figure 71 : Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 72 : Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 73 : GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 74 : GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2019
  • Figure 75 : GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 76 : GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 77 : Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 78 : Novartis AG Breakdown of Net Sales (%), by Country, 2019
  • Figure 79 : Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 80 : Novartis AG Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 81 : Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 82 : Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 83 : Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Segment, 2019
  • Figure 84 : Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2019
  • Figure 85 : Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
  • Figure 86 : Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2019
  • Figure 87 : Breakdown of Sumitomo Dainippon Pharma Co., Ltd Net Sales (%), by Product Segment, 2017
  • Figure 88 : Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 89 : Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2019
  • Figure 90 : Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 91 : Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 92 : F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 93 : F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2019
  • Figure 94 : F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 95 : F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 96 : Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 97 : Sanofi Breakdown of Net Sales (%), by Region, 2019
  • Figure 98 : Sanofi Revenue Breakdown of Net Sales (%), by Business segment, 2019
  • Figure 99 : Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 100 : Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
  • Figure 101 : Mylan N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2019
  • Figure 102 : Mylan N.V. Breakdown of Net Sales (%), by Region, 2019

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report